COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,833 Articles (22,553 medRxiv, 8,280 bioRxiv)

Most recent first Previous |  Page 17: Articles 161-170  | Next

Estimating Excess Mortality Among People Living with HIV/AIDS During the COVID-19 Pandemic in the USA
Hall, L., Chowell, G.
10.1101/2025.06.09.25329225 — Posted: 2025-06-10
COVID-19 Increases the Rate of Incident Hypertension: A Case-Control Cohort Time-to-Event Study
Goldhaber-Fiebert, J. D., Phillips, S. C., Lucas, K. D., Jacobsen, D. A., Studdert, D. M.
10.1101/2025.06.09.25329275 — Posted: 2025-06-10
COVID-19 Increases the Rate of Incident Diabetes: A Case-Control Cohort Time-to-Event Study
Goldhaber-Fiebert, J. D., Phillips, S. C., Lucas, K. D., Jacobsen, D. A., Studdert, D. M.
10.1101/2025.06.09.25329289 — Posted: 2025-06-10
Acute anaphylactic and multiorgan inflammatory effects of Comirnaty in pigs: evidence of spike protein mRNA transfection and paralleling inflammatory cytokine upregulation
Dezsi, L., Kokeny, G., Szeneasi, G., Revesz, C., Meszaros, T., Barta, B., Facsko, R., Szilasi, A., Bakos, T., Kozma, G. T., Dobos, A., Merkely, B., Radovits, T., Szebeni, J.
10.1101/2025.06.07.658379 — Posted: 2025-06-10
Optimal dose and safety of intravenous favipiravir in hospitalised patients with SARS-CoV-2 infection: a Phase Ib, open-label, dose-escalating, randomised controlled study
Rowland, T., FitzGerald, R., Challenger, E., Dickinson, L., Else, L., Walker, L., Hale, C., Shaw, V., Kelly, C., Lyon, R., Gibney, J., Dhamani, K., Irwin, M., Enever, Y., Tetlow, M., Wood, W., Reynolds, H., Chiong, J., Osanlou, O., Pertinez, H., Bullock, K., Greenhalf, W., Owen, A., Lalloo, D. G., Jacobs, M., Hiscox, J. A., Jaki, T., Mozgunov, P., Saunders, G., Griffiths, G., Khoo, S. H., Fletcher, T., the AGILE CST-6 study group
10.1101/2025.06.09.25329141 — Posted: 2025-06-09
The impact of the COVID-19 pandemic on end of life care in LTCFs in England: A qualitative study of LTCF staff experiences
Cotterell, N., Collingridge Moore, D.
10.1101/2025.06.09.25328142 — Posted: 2025-06-09
'It's like the spirit of the blitz': the impact of the COVID-19 pandemic on LTCF staff working relationships in England.
Collingridge Moore, D., Cotterell, N.
10.1101/2025.06.09.25328141 — Posted: 2025-06-09
Conformational Landscaping and Dynamic Mutational Profiling of Binding Interactions and Immune Escape for Broadly Neutralizing Class I Antibodies with SARS-CoV-2 Spike Protein: Distributed Binding Hotspot Networks Underlie Mechanism of Viral Resistance Against Existing Variants
Alshahrani, M., Parikh, V., Foley, B., Verkhivker, G.
10.1101/2025.06.07.658468 — Posted: 2025-06-09
Identification of reactive CpGs and RNA expression in early COVID-19 through cis-eQTM analysis reflecting disease severity and recovery
Ryu, H., An, K., Kwon, Y., Jeon, Y., Jeon, S., Choi, H., Kim, Y. J., Kim, S., Sul, O. J., Lee, S., Chun, A. Y., Shin, E.-S., Ra, S. W., Bhak, J.
10.1101/2025.06.09.658549 — Posted: 2025-06-09
SARS-CoV-2 reshapes mA methylation in long non-coding RNAs of human lung cells
Peter, C. M., Cyrino, C. O., Moretti, N. R., Antoneli, F., Briones, M. R.
10.1101/2025.06.08.658496 — Posted: 2025-06-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).